Search research articles
Contact Us
Filters
Showing results (1021-1030 of 1,190) with videos related to
Page
of 119
Sort By:
Nature Communications
|
March 7, 2026
Accurate atomic resolution XFEL structures of a metalloenzyme reveal key insights into its catalytic mechanism
Samuel L Rose, Svetlana Antonyuk, Felix F Ferroni, et al.
Journal of the Canadian Association of Gastroenterology
|
July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
Keeley L Rose, Philip M Sherman, Jane Cooke-Lauder, et al.
AIDS and Behavior
|
July 27, 2022
Gender Moderates Results of a Randomized Clinical Trial for the Khanya Intervention for Substance Use and ART Adherence in HIV Care in South Africa
Jennifer M Belus, John A Joska, Yosef Bronsteyn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 12, 2009
Proteome-wide prediction of acetylation substrates
Amrita Basu, Kristie L Rose, Junmei Zhang, et al.
Radiology
|
December 1, 2020
False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis
Melissa A Durand, Sarah M Friedewald, Donna M Plecha, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions
Emmy Li, Camila Benitez, Steven C Boggess, et al.
BMC Biology
|
December 17, 2009
Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates
Deanna Dryhurst, Toyotaka Ishibashi, Kristie L Rose, et al.
Nature Communications
|
June 17, 2024
Low potassium activation of proximal mTOR/AKT signaling is mediated by Kir4.2
Yahua Zhang, Fabian Bock, Mohammed Ferdaus, et al.
Plos Genetics
|
January 14, 2026
Impact of maternal compensation on developmental phenotypes in a zebrafish model of severe congenital muscular dystrophy
Kyle P Flannery, Shorbon Mowla, Namarata Battula, et al.
Cancer
|
January 5, 2024
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade
Eric J Miller, Tracy L Rose, Benjamin L Maughan, et al.
Page
of 119
Search research articles
Search
Showing results (1021-1030 of 1,190) with videos related to
Sort By:
Page
of 119
Nature Communications
|
March 7, 2026
Accurate atomic resolution XFEL structures of a metalloenzyme reveal key insights into its catalytic mechanism
Samuel L Rose, Svetlana Antonyuk, Felix F Ferroni, et al.
Journal of the Canadian Association of Gastroenterology
|
July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada
Keeley L Rose, Philip M Sherman, Jane Cooke-Lauder, et al.
AIDS and Behavior
|
July 27, 2022
Gender Moderates Results of a Randomized Clinical Trial for the Khanya Intervention for Substance Use and ART Adherence in HIV Care in South Africa
Jennifer M Belus, John A Joska, Yosef Bronsteyn, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 12, 2009
Proteome-wide prediction of acetylation substrates
Amrita Basu, Kristie L Rose, Junmei Zhang, et al.
Radiology
|
December 1, 2020
False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis
Melissa A Durand, Sarah M Friedewald, Donna M Plecha, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
CRISPRi-based screens in iAssembloids to elucidate neuron-glia interactions
Emmy Li, Camila Benitez, Steven C Boggess, et al.
BMC Biology
|
December 17, 2009
Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates
Deanna Dryhurst, Toyotaka Ishibashi, Kristie L Rose, et al.
Nature Communications
|
June 17, 2024
Low potassium activation of proximal mTOR/AKT signaling is mediated by Kir4.2
Yahua Zhang, Fabian Bock, Mohammed Ferdaus, et al.
Plos Genetics
|
January 14, 2026
Impact of maternal compensation on developmental phenotypes in a zebrafish model of severe congenital muscular dystrophy
Kyle P Flannery, Shorbon Mowla, Namarata Battula, et al.
Cancer
|
January 5, 2024
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade
Eric J Miller, Tracy L Rose, Benjamin L Maughan, et al.
Page
of 119